|
Dr. Hébert supervises the Corporate Communications program, including the Investor Relations program. She is in charge of developing and implementing the communications and investor relations strategies, in line with the Company's development objectives.
Before joining Neurochem, Dr. Hébert was Executive Director of the Federation of Quebec Alzheimer Societies for six years. She holds a Ph.D in Experimental Medicine from McGill University on amyloidosis and finished post-doctoral studies where she investigated the mechanism of programmed cell death as found in Alzheimer's disease.
Dr. Hébert has also completed the Canadian Securities Course from the Canadian Securities Institute. | 